Comments to FDA: Considering Whether an FDA-Regulated Product Involves the Application of Nanotechnology Share page: Docket Number: FDA-2010-D-0530 CHPA applauds the approach for creating a public forum to collect current research and comments to advance the science of engineered nanomaterials. Download Document Issues: OTC Medicines Sunscreen Other Issues Quality Related Posts Comments Comments Regarding Control of Nitrosamine Impurities in Human Drugs Dec 20, 2024 Press Releases and Statements Rates for Teen Abuse of OTC Cough/Cold Medication Remains Low According to NIDA Survey Dec 18, 2024 Pediatric Cough/Cold Dosing